Celltrion at BioUSA... "Considering Strengthening New Drug Competitiveness"

Celltrion announced on the 5th that it will participate in the 'Bio International Convention (Bio USA) 2023,' held over four days from the 5th to the 8th (local time) in Boston, Massachusetts, USA, to engage in global partnering activities.

The Celltrion booth at the 'BIO USA 2023' exhibition venue held from the 5th to the 8th (local time) [Photo by Celltrion]

Celebrating its 30th edition this year, Bio USA is considered the largest event in the global pharmaceutical and biotechnology sectors. Celltrion has participated in Bio USA annually since 2010, and this year, it has set a goal to actively expand its global presence and prepare to leap forward as a top-tier pharmaceutical and biotech company. Accordingly, it plans to focus on expanding its global network through strengthened partnering.

To this end, Celltrion will set up a standalone booth at the exhibition hall, providing open meeting spaces and private meeting rooms to conduct meetings with various global companies, while also promoting its proprietary technological competitiveness and brand activities.

Celltrion aims to explore potential partners possessing technologies across a broad range of new drug fields, including platform technologies for discovering new modalities (therapeutic approaches) such as follow-up biosimilar pipelines, antibody-drug conjugates, bispecific antibodies, antibody new drugs, and microbiomes, and plans to engage in discussions for future joint development.

A Celltrion representative stated, “To advance beyond being a biosimilar company to a new drug development company, we are examining various business expansion strategies, including strengthening in-house development capabilities, joint development, open innovation, and mergers and acquisitions (M&A). Through this Bio USA, we will do our best to seek partnerships with diverse companies that can add synergy to our accumulated pharmaceutical development experience and technological competitiveness.”

Meanwhile, Celltrion is also expected to participate in ‘CPhI Worldwide 2023,’ the world’s largest pharmaceutical and biotech conference held in Europe in the second half of this year, to enhance its corporate brand competitiveness and further strengthen global partnering.

This content was produced with the assistance of AI translation services.